FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1231759003: Product containing precisely diclofenac potassium 50 milligram and paracetamol 325 milligram and serrapeptase 10 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5074153019 Diclofenac potassium 50 mg and paracetamol 325 mg and serrapeptase 10 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5074154013 Acetaminophen 325 mg and diclofenac potassium 50 mg and serrapeptase 10 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5074155014 Product containing precisely diclofenac potassium 50 milligram and paracetamol 325 milligram and serrapeptase 10 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Acetaminophen 325 mg and diclofenac potassium 50 mg and serrapeptase 10 mg oral tablet a une forme pharmaceutique (attribut) Oral tablet true Inferred relationship Some
Acetaminophen 325 mg and diclofenac potassium 50 mg and serrapeptase 10 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Acetaminophen 325 mg and diclofenac potassium 50 mg and serrapeptase 10 mg oral tablet Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 1
Acetaminophen 325 mg and diclofenac potassium 50 mg and serrapeptase 10 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Acetaminophen 325 mg and diclofenac potassium 50 mg and serrapeptase 10 mg oral tablet Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 2
Acetaminophen 325 mg and diclofenac potassium 50 mg and serrapeptase 10 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2
Acetaminophen 325 mg and diclofenac potassium 50 mg and serrapeptase 10 mg oral tablet Has precise active ingredient Serrapeptase true Inferred relationship Some 3
Acetaminophen 325 mg and diclofenac potassium 50 mg and serrapeptase 10 mg oral tablet Has basis of strength substance (attribute) Serrapeptase true Inferred relationship Some 3
Acetaminophen 325 mg and diclofenac potassium 50 mg and serrapeptase 10 mg oral tablet Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 3
Acetaminophen 325 mg and diclofenac potassium 50 mg and serrapeptase 10 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 3
Acetaminophen 325 mg and diclofenac potassium 50 mg and serrapeptase 10 mg oral tablet est un(e) (attribut) Acetaminophen and diclofenac and serrapeptase only product in oral dose form true Inferred relationship Some
Acetaminophen 325 mg and diclofenac potassium 50 mg and serrapeptase 10 mg oral tablet Has precise active ingredient Acetaminophen true Inferred relationship Some 1
Acetaminophen 325 mg and diclofenac potassium 50 mg and serrapeptase 10 mg oral tablet Has basis of strength substance (attribute) Acetaminophen true Inferred relationship Some 1
Acetaminophen 325 mg and diclofenac potassium 50 mg and serrapeptase 10 mg oral tablet Has precise active ingredient Diclofenac potassium true Inferred relationship Some 2
Acetaminophen 325 mg and diclofenac potassium 50 mg and serrapeptase 10 mg oral tablet Has basis of strength substance (attribute) Diclofenac potassium true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start